Company / Net Income
Oruka Therapeutics, Inc. Net Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$83.7M
FY2024
5-year range
-$83.7M / -$5.3M
FY2020-FY2024
Trend
-1468.2%
vs FY2023
Sector context
#103 of 216
Health Care
What the data says
Net Income changed -1468% YoY in FY2024, a notable deviation from the 9-year average annual change of -173%.
Based on SEC 10-K filings.
-$84M in FY2024.
Declined from -$19M to -$84M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 216 in Health CareTop 48% of 216This company -$83.7M Sector average $454.1M
▼
-118.4% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 1468.2% year-over-year.
- Ranks #103 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$83.7M | -1468.2% |
| FY2023 | -$5.3M | +72.4% |
| FY2022 | -$19.3M | -98.4% |
| FY2021 | -$9.7M | -77.6% |
| FY2020 | -$5.5M | +30.9% |
| FY2019 | -$7.9M | +57.1% |
| FY2018 | -$18.5M | -12.4% |
| FY2017 | -$16.4M | -43.7% |
| FY2016 | -$11.4M | -18.1% |
| FY2015 | -$9.7M | -39.6% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026